Nature Biotechnology
Scope, open access and whether your paper fits
Nature Biotechnology is a medicine journal published by Nature Portfolio since 1941. Below: what it publishes, its open-access status and citation figures from OpenAlex, and a short checklist for deciding whether to submit there.
- Publisher
- Nature Portfolio
- Field
- Medicine · Public Health, Environmental and Occupational Health
- Access
- Subscription, with an open-access option listed at about $12,690
- h-index
- 630
- 2-year mean citedness
- 13.67
- Works indexed
- 20,264
- ISSN-L
- 0733-222X
What it publishes
The topics Nature Biotechnology publishes most on, according to OpenAlex:
- Biotechnology and Related Fields
- Pharmaceutical Economics and Policy
- Genetically Modified Organisms Research
- CRISPR and Genetic Engineering
- Intellectual Property and Patents
- Biomedical Ethics and Regulation
- Genomics and Phylogenetic Studies
- RNA Interference and Gene Delivery
How much it publishes
| Year | Works indexed in OpenAlex |
|---|---|
| 2026 | 394 |
| 2025 | 436 |
| 2024 | 468 |
| 2023 | 467 |
| 2022 | 429 |
| 2021 | 395 |
The latest year may be incomplete while indexing catches up.
Is your paper a fit?
- Read the aims and scope on the journal’s own site: OpenAlex topics describe what it has published, not what it wants next.
- Look at the titles of the last two issues: has it published work like yours recently?
- Check the article types it accepts, word limits and any reporting checklist it requires.
- Check the article fee, waivers and your funder’s open-access rules.
- Compare it with similar journals below, and use the free journal finder to see where papers like yours were published.
About these figures
Data from OpenAlex (CC0), retrieved 2026-10-22. The h-index and 2-year mean citedness are computed by OpenAlex; 2-year mean citedness is similar in spirit to an impact factor but is not the Clarivate Journal Impact Factor. NoveltyAxis is not affiliated with this journal or its publisher.
Questions
Is Nature Biotechnology open access?
Subscription, with an open-access option listed at about $12,690. Fees change, so confirm on the journal’s site.
What is the h-index of Nature Biotechnology?
630, according to OpenAlex: at least that many of its papers have each been cited at least that many times.
Is Nature Biotechnology the right journal for my paper?
Only if your paper fits its scope and recent content. Run a pre-submission review to see whether the draft is ready, and the journal finder to compare where similar papers were published.